Comparison of the diagnostic performance of high-frequency ultrasound as a first- or second-line diagnostic tool in non-palpable lesions of the breast

Abstract

To compare the diagnostic performance of high-frequency ultrasound (HFU) as a first- or second-line diagnostic tool in non-palpable lesions (NPL) of the breast and to define the place of HFU in the diagnostic process, 89 women with this kind of lesion, previously detected by mammography, underwent HFU with 7.5-13 MHz transducers. The examinations were performed by two equally experienced operators of which only one (operator I) was aware of the mammographic findings. The mammographic examinations revealed the following non-palpable lesions: asymmetry-hyperdensity (17 cases), nodule (44 cases), stellate lesion (5 cases), microcalcifications (23 cases). Total sensitivity of HFU in the examinations performed by operator I was 83 %, while in the examinations performed by operator II (unaware of the mammographic findings) it was only 35 %. In all cases HFU allowed the operators to determine the basic features of the lesions. Our experience confirms that ultrasonography, even if performed with high frequency, cannot be proposed as a screening examination but may profitably be employed as a second-step technique to characterize NPL previously identified by mammography. This 'second-step' role can do the following: rule out true pathology (cases of false-positive mammography findings); furnish some basic features in the case of focal lesions; show other findings in the case of microcalcifications, such as microcysts, 'filled duct' appearance, parenchymal inhomogeneities and nodules; guide interventional procedures; and localize lesions preoperatively.

Breast Cancer Detection In Patients Younger Than 40 Years Old In an Opportunistic Screening Population

“…The (USG) plays an important role for diagnosis of BC at an early stage in women who are in high-risk group for (BC) and in patients with dense breasts (24)(25)(26). It has a sensitivity of more than 95%, and is the preferred initial imaging technique in this patient group.…”

Comparison of mammography and ultrasound in detecting residual disease following bioptic lumpectomy in breast cancer patients

“…Of the 69 residual DCISs, 65 (94.2%) were visible on MMG as abnormal lesions, with or without microcalcifications. Compared with MMG, only 23 residual disease cases with DCIS were detected by US, which indicates that MMG may be more effective compared with US in the detection of residual DCIS (26,27).…”

Additional Breast Ultrasound Examinations in Clustered Calcifications: for Improving Diagnostic Performance

“…However, US has low sensitivity as a primary imaging modality for the detection of calcifications, which remains its major limitation. (9) Furthermore, when calcifications are located inside echogenic, fibroglandular breast tissues, they may not be depicted by US because it is difficult to differentiate them from echogenic interfaces among tissues. However, US can detect associated masses or ductal changes in patients with calcifications, thus, US might be a feasible secondline additional diagnostic tool.…”